AagingBase | Database of anti-aging peptide

Peptide Card for AAPeptide265


The Peptide Card page for AAPeptide265 gives textual and graphical visualizations of the properties of AAPeptide265. The users can find all the literature informations collected from scholarly articles and patents and the calculated physicochemical informations. There are also graphical representations hydropathy values, amino acid compositions and frequencies, atomic compositions and secondary structure fractions of AAPeptide265.
To obtain further details, refer to the Help page.


AAP IDAAPeptide265
Peptide nameTELODIN (DKY21)
PubMed/Patent IDUS 11365217 B2,US 11246818 B2,US 2021/0040152 A1
OriginNatural
Source of OriginHuman
Condition addressedSkin aging
Experiment typeIn vitro, In vivo
Cell lines/Animal modelHuman cervical carcinoma cells (Hela), 3-6 month old wild mice
InterventionCells were treated with the peptide, Topical application of the peptide on the mice after X-ray irradiation,Mice were intratracheally perfused with the peptide, Cells were treated with the peptide
Experiment methodsqRT-PCR, Immunofluorescence assay, Western Blot, Masson and H&E staining, Fluorescence in situ hybridization (FISH)
Patient groupNA
Markers usedα-SMA, Col6α and MMP3,α-SMA, Col6α and MMP5,α-SMA
Mechanism of actionAlleviates the respiratory dysfunction in mice, Reduces the expression of TPP1, the telomere shortening, Decreases the proportion of type II epithelial cells and pulmonary fibrosis caused by the overexpression of FBW7, Inhibits the telomere DNA damage caused by irradiation of X rays
Molecular weight2620.889
Peptide length21
Instability index127.333
Aromaticity0.048
Aliphaticity0.143
Reduced molecular extinction coeffecient1490
Oxidized molecular extinction coeffecient1490
Isoelectric point11.630
Composition of positively charged residues0.476
Composition of negatively charged residues0.143
Composition of neutral charged residues0.381
Composition of residues polar residues0.190
Composition of residues non-polar residues0.143
Composition of residues having cyclic side chain0.000
Composition of acidic residues0.143
Composition of basic residues0.476
Composition of residues having cyclic side chain0.000
Composition of hydroxylic residues0.143
Composition of residue in buried solvent accessibility0.143
Composition of residue in exposed solvent accessibility0.333
Composition of residue in intermediate solvent accessibility0.190

AAPeptide265 :
YGRKKRRERRRGSRNGTEETK

Amino acid data
ProtScale
Atomic information


3D Structure

Structural Representation of AAPeptide265

Amino acid data
Secondary structure fraction